“…9 The formation and accumulation of AGEs in vivo have drawn major attention because of their possible association with the aging process as well as the development of chronic diseases, such as Alzheimer's disease, atherosclerosis, chronic inflammatory diseases, cardiovascular diseases, or diabetes mellitus and its numerous long-term complications.10−13 Human plasma levels for 3-deoxyglucosone (3-DG), methylglyoxal (MGO), and glyoxal (GO) have been estimated to reach 0.16−1.24 μmol/L, increasing to values of 4.09 μmol/L in diabetes and uremic patients and thus contributing to systemic carbonyl stress.14 Pharmaceutical interventions against glycation were initially carried out with substances such as aminoguanidine; however, their relevant side effects in clinical trials have led to the search for natural products with the same ability.12,15 Natural plant extracts are the priority source for searching compounds that mitigate the formation of AGEs,15 although recently the antiglycative activity of other naturally occurring substances such as creatine has been highlighted. 16 Because certain stages of the glycation process are driven by redox reactions, polyphenols have been largely investigated by applying their antioxidant capacity to mitigate the radical-mediated reactions. Moreover, the ability of certain polyphenols to trap reactive carbonyl species has recently been pointed out.13,15,17 However, investigations on the carbonyl trapping activity have only been carried out with MGO and GO, whereas their activity against C6 α-dicarbonyl compounds has not been determined, although these compounds are mostly present in higher concentrations than C2 and C3 α-dicarbonyl structures.4 Additionally, 3-DG is the most abundant C6 α-dicarbonyl in vivo, ranging from 35 to 56 pmol/mL in plasma of healthy subjects.1,11…”